首页 | 本学科首页   官方微博 | 高级检索  
     

复方苦参注射液对直肠癌患者CEA、CA199及生活质量的影响
引用本文:王奕,唐求,龙志雄. 复方苦参注射液对直肠癌患者CEA、CA199及生活质量的影响[J]. 中国肿瘤临床与康复, 2011, 0(3): 285-286
作者姓名:王奕  唐求  龙志雄
作者单位:武汉市中心医院;武汉市第五医院;
摘    要:目的探讨复方苦参注射液对直肠癌患者肿瘤标志物CEA、CA199及生活质量的影响。方法将58例直肠癌患者随机分成两组,治疗组29例应用FOLFOX-4方案加复方苦参注射液静脉滴注,对照组29例应用FOLFOX-4方案。比较直肠癌患者使用复方苦参注射液前后CEA、CA199检测值及生活质量评分的变化。结果治疗组优于对照组,治疗组在化疗结束后第12天CEA为(4.23±0.50)ng/L,CA199为(18.11±3.14)ng/ml,均低于化疗结束后第一天CEA(5.34±0.48)ng/L,CA199(26.31±2.36)ng/L,但两者差异无显著性(P>0.05);对照组在化疗结束后第1天和第12天CEA和CA199的值变化不大,差异亦无显著性。治疗组Karnofsky降低率(17.2%)明显低于对照组(48.3%),两者差异有显著性(P<0.05)。结论复方苦参注射液可降低直肠癌康复期患者CEA及CA199水平,但差异无显著性。复方苦参注射液治疗能提高KPS得分,有效改善生存质量,差异有显著性。

关 键 词:复方苦参注射液  直肠肿瘤  肿瘤标志物  生存质量

The effect of Yan-shu Injection on tumor markers(CEA,CA199)and quality of life in rectal cancer patients
WANG Yi ,TANG Qiu,LONG Zhi-xiong. The effect of Yan-shu Injection on tumor markers(CEA,CA199)and quality of life in rectal cancer patients[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2011, 0(3): 285-286
Authors:WANG Yi   TANG Qiu  LONG Zhi-xiong
Affiliation:WANG Yi 1,TANG Qiu1,LONG Zhi-xiong2(1.Wuhan Central Hospital,Wuhan 430014,China,2.The Fifth Municipal Hospital of Wuhan,China)
Abstract:Objective To study the effect of Yan-shu Injection on tumor markers(CEA,CA199)and quality of life in rectal cancer patients.Methods A total of 58 patients with rectal cancer were enrolled,29 were randomized to treatment group(chemotherapy plus Yan-shu) and 29 to control group(chemotherapy).The regimen of FOLFOX-4 was taken for chemotherapy.The variation of tumor markers(CEA,CA199) in peripheral blood and quality of life before and after therapy with Yan-shu Injection were observed.Results The levels of CEA(...
Keywords:Yan-shu Injection  Rectal neoplasms  Tumor markers  Quality of life  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号